Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseases

被引：0
|
作者：
Amihai, R. [1 ]
Mishael, T. [2 ]
Grisaru-Granovski, S. [2 ]
Koslowsky, B. [2 ]
Abitbol, G. [2 ]
Goldin, E. [2 ]
Shitrit, A. Bar-Gil [2 ]
机构：
[1] Hadassah Hebrew Univ, Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel
[2] Shaare Zedek Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P155
引用
收藏
页码：S215 / S216
页数：2
相关论文
共 50 条
  • [21] Utility of Fecal Calprotectin Levels for the Diagnosis of Inflammatory Bowel Disease in Patients with Spondyloarthritis
    Espinosa, Maria
    Ramos Giraldez, Consuelo
    Merino, Carolina
    Ruiz Antoran, Belen
    Campos, Jose
    Barbadillo, Carmen
    Godoy, Hilda
    Agudo, Belen
    Gonzalez, Yago
    Luis Andreu, Jose
    Sanz, Jesus
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [22] The Utility of Fecal Calprotectin in an Acute Flare of Inflammatory Bowel Disease
    Wilen, Jonathan
    Kumar, Shria
    Lichtiger, Simon
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S404 - S404
  • [23] The Utility of Fecal Calprotectin in an Acute Flare of Inflammatory Bowel Disease
    Kumar, Shria
    Lichtiger, Simon
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S310 - S311
  • [24] Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients
    Dai, Cong
    Cao, Qin
    Jiang, Min
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (04) : 314 - 314
  • [25] Can fecal Calprotectin anticipate the future clinical activity in patients with quiescent Inflammatory Bowel Disease?
    Shah, Rushikesh
    Herrera, Henry
    Dewald, Rosemarie
    Swaroop, Prabhakar
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S40 - S41
  • [26] The value of Fecal Markers in Predicting Relapse in inflammatory Bowel Diseases
    Galgut, Bianca J.
    Lemberg, Daniel A.
    Day, Andrew S.
    Leach, Steven T.
    FRONTIERS IN PEDIATRICS, 2018, 5
  • [27] THE UTILITY OF SERUM CALPROTECTIN AS A BIOMARKER IN PREDICTING INFLAMMATORY BOWEL DISEASE
    Kalla, R.
    Kennedy, N. A.
    Ventham, N. T.
    Visconti, M.
    Adams, A.
    Jarvie, A.
    Pattenden, R.
    Satsangi, J.
    GUT, 2015, 64 : A433 - A433
  • [28] FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
    Rosenfeld, Greg
    Greenup, Astrid-Jane
    Round, Andrew
    Takach, Oliver
    Halparin, Lawrence
    Saadeddin, Abid
    Ho, Jin Kee
    Lee, Terry
    Enns, Robert
    Bressler, Brian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (36) : 8211 - 8218
  • [29] Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease
    Shapur Ikhtaire
    Mohammad Sharif Shajib
    Walter Reinisch
    Waliul Islam Khan
    Journal of Gastroenterology, 2016, 51 : 434 - 446
  • [30] Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease
    Ikhtaire, Shapur
    Shajib, Mohammad Sharif
    Reinisch, Walter
    Khan, Waliul Islam
    JOURNAL OF GASTROENTEROLOGY, 2016, 51 (05) : 434 - 446
12345